Sinil Pharmaceutical Co. Ltd (012790) — Financial Flexibility Index
Sinil Pharmaceutical Co. Ltd (012790) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of ₩2.84 Billion (operating CF ₩2.62 Billion minus capex ₩213.15 Million) represents 0% of total liabilities (₩18.23 Billion). Check Sinil Pharmaceutical Co. Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinil Pharmaceutical Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Sinil Pharmaceutical Co. Ltd across 11 annual periods. See how liquid is Sinil Pharmaceutical Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sinil Pharmaceutical Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Sinil Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 012790 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.61x | ₩31.16 Billion | ₩22.69 Billion | ₩19.36 Billion | ▲ +0.7% |
| 2023 | 1.60x | ₩28.08 Billion | ₩15.15 Billion | ₩17.56 Billion | ▲ +35.8% |
| 2022 | 1.18x | ₩23.02 Billion | ₩13.69 Billion | ₩19.55 Billion | ▲ +25.5% |
| 2021 | 0.94x | ₩14.79 Billion | ₩11.16 Billion | ₩15.78 Billion | ▼ -18.2% |
| 2020 | 1.15x | ₩19.86 Billion | ₩11.06 Billion | ₩17.33 Billion | ▼ -13.7% |
| 2019 | 1.33x | ₩22.04 Billion | ₩12.31 Billion | ₩16.59 Billion | ▼ -15.0% |
| 2018 | 1.56x | ₩17.53 Billion | ₩9.19 Billion | ₩11.22 Billion | ▲ +0.3% |
| 2017 | 1.56x | ₩18.05 Billion | ₩8.67 Billion | ₩11.59 Billion | ▲ +15.4% |
| 2016 | 1.35x | ₩14.66 Billion | ₩12.09 Billion | ₩10.86 Billion | ▼ -20.1% |
| 2015 | 1.69x | ₩15.37 Billion | ₩9.56 Billion | ₩9.09 Billion | ▲ +32.3% |
| 2014 | 1.28x | ₩11.57 Billion | ₩9.33 Billion | ₩9.06 Billion | — |